Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials
African Health Sciences · 2023
DOI: 10.4314/ahs.v23i3.25 ↗Kurz gefasst
Metaanalyse in der Zeitschrift African Health Sciences, 2023. Verfasst von Lunbo Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of hematological oncology chemotherapy, Fenghua District People's Hospital of Ningbo, Zhejiang, China. Hauptthemen laut MEDLINE: Anemia, Iron-Deficiency, Disaccharides, Ferric Compounds, Ferrosoferric Oxide. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
The efficacy of iron isomaltoside ferumoxytol versus iron sucrose to treat iron deficiency anemia remains controversial. We conduct this meta-analysis to explore the influence of iron isomaltoside ferumoxytol versus iron sucrose on iron deficiency anemia.
Methods
We have searched PubMed, EMbase, Web of science, EBSCO, and Cochrane library databases through March 2021 for randomized controlled trials (RCTs) assessing the effect of iron isomaltoside ferumoxytol versus iron sucrose on iron deficiency anemia. Meta-analysis was performed using the random-effect model.
Results
Four RCTs involving 3892 patients were included in the meta-analysis. Overall, compared with iron sucrose for iron deficiency anemia, iron isomaltoside showed similar change of Hb (SMD=0.14; 95% CI=-0.07 to 0.35; P=0.18), Hb responder (SMD=1.41; 95% CI=0.71 to 2.81; P=0.33), serum ferritin (SMD=15.13; 95% CI=-23.45 to 53.71; P=0.44), and transferrin saturation (SMD=1.20; 95% CI=-1.08 to 3.47; P=0.30). However, iron isomaltoside further improved serum-ferritin at week 2 than iron sucrose (SMD=204.79; 95% CI=38.23 to 371.35; P=0.02).
Conclusions
Iron isomaltoside ferumoxytol showed comparable efficacy to iron sucrose for the treatment of iron deficiency anemia. Keywords: Iron isomaltoside ferumoxytol; iron sucrose; iron deficiency anemia; randomized controlled trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of hematological oncology chemotherapy, Fenghua District People's Hospital of Ningbo, Zhejiang, China.
Zitieren
APA
Shi, L., Zhao, Y., & Rao, A. (2023). Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials. African Health Sciences. https://doi.org/10.4314/ahs.v23i3.25
Vancouver
Shi L, Zhao Y, Rao A. Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials. African Health Sciences. 2023. doi:10.4314/ahs.v23i3.25
BibTeX
@article{Shi2023,
author = {Shi, Lunbo and Zhao, Yan and Rao, Aihua},
title = {Comparison of iron isomaltoside ferumoxytol with iron sucrose for iron deficiency anemia: a meta-analysis of randomized controlled trials},
journal = {African Health Sciences},
year = {2023},
doi = {10.4314/ahs.v23i3.25}
}
EUVIMED